HEALTHJul 31 · 13:27 UTCKTLA 5Patrick Djordjevic

GLP-1 drugs could become personalized for individuals, study says

A study suggests GLP-1 drugs could become personalized for individuals, with higher-dosage GLP-1 agonists showing greater cardiometabolic improvements.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

GLP-1 drugstopiccardiometabolic improvementstopicGLP-1 agoniststopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJul 31 · 10:44 UTC
GLP-1 drugs could become personalized for individuals, study says
HEALTHApr 8 · 00:00 UTC
Genetic predictors of GLP1 receptor agonist weight loss and side effects
HEALTHMay 21 · 21:02 UTC
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
HEALTHJun 20 · 08:00 UTC
Should everyone be on GLP-1s? What the science really tells us about cancer prevention and other benefits
HEALTHJul 25 · 00:40 UTC
GLP-1s are changing US healthcare, should everyone be on them?